Wai Lee, MD
Urogynecology and Reconstructive Pelvic Surgery · New Hyde Park, NYNPI 1861752347
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,523 of the $17,429 with a category attached, or 60.4%. 15 manufacturers reported payments, led by Medtronic at 53.5% of the total. Reporting peaked in 2022 at $3,829 and has fallen 66.0% since, to $1,302 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $70.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Caldera Medical, Inc$2K
- AbbVie$1K
- Axonics, Inc.$1K
- Intuitive Surgical$1K
- Valencia Technologies Corporation$809
- plus $1K from 9 others
Across 1 payment — averaging $355.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$355
What the payments were for
- Consulting fees$6434%
- Speaking & faculty fees$3502%
- Travel & lodging$5,64932%
- Food & beverage$10,52360%
- Gifts$2491%
- Entertainment$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 158 | $9,316 |
| Caldera Medical, Inc | 11 | $2,099 |
| AbbVie(2 entities) | 37 | $1,410 |
| Axonics, Inc. | 16 | $1,320 |
| Intuitive Surgical | 8 | $1,228 |
| Valencia Technologies Corporation | 3 | $809 |
| Teleflex LLC | 1 | $350 |
| Boston Scientific | 6 | $274 |
| Calyxo, Inc. | 1 | $136 |
| Coloplast | 2 | $133 |
| Cook Medical LLC | 1 | $105 |
| Astellas Pharma Global Development | 1 | $100 |
| Astellas Pharma US Inc | 1 | $78 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Bluewind Medical | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$4,875
- Desara$1,669
- Da Vinci Surgical System$907
- eCoin Device Kit$715
- Bulkamid$691
- Axonics r-SNM System$691
- BOTOX$599
- Barrigel$350
- Axonics$288
- DA VINCI SP$207
- INTERSTIM ICON$160
- CVAC Aspiration System$136
- ADVANTAGE FIT$123
- VERIFY$122
- Cook Medical Holmium Laser Fiber$105
- ALTIS$101
How this compares
$17,429 in reported general payments places this provider in the 90th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.
See all urogynecology and reconstructive pelvic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 136 | $107,452 |
| GemtesaVibegron | 53 | $45,422 |
| Estradiol | 376 | $27,912 |
| Tamsulosin Hcl | 363 | $6,407 |
| Trospium Chloride | 121 | $5,628 |
| Methenamine Hippurate | 23 | $3,416 |
| Silodosin | 26 | $2,377 |
| Finasteride | 107 | $1,576 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 89 | $1,103 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 32 | $606 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $542 |
| Solifenacin Succinate | 16 | $530 |
| Cephalexin | 17 | $148 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 45 | $92 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $83 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $78 | $107,452136 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $50 | $45,42253 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.
Other urogynecology and reconstructive pelvic surgery in New Hyde Park
- Robert MoldwinNew Hyde Park$35K
- Doreen ChungNew Hyde Park$14K
- Jason KimStony Brook$346K
- Dara ShalomGreat Neck$94K
- Harvey WinklerGreat Neck$81K
- Nitya AbrahamBronx$24K
- Cornelius VerhoestPoughkeepsie$21K
- Abeer EddibCheektowaga$19K
- Jennifer HillRiverhead$13K
- Ido SirotaNew York$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.